LOINCActiveBoth

LOINC Code 94209-4: NAGLU gene full mutation analysis Sequencing Doc (Bld/Tiss)

94209-4 is a LOINC code used to identify NAGLU gene full mutation analysis Sequencing Doc (Bld/Tiss) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component NAGLU gene full mutation analysis. It is commonly used with the system or sample type Bld/Tiss.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component NAGLU gene full mutation analysis. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Sequencing

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

NAGLU gene full mutation analysis in Blood or Tissue by Sequencing
NAGLU gene full mutation analysis
Full sequence analysis is performed to test for the presence of a mutation in all coding regions and intron/exon boundaries of the NAGLU gene to confirm a diagnosis of mucopolysaccharidosis type IIIB. Testing may also be performed on at-risk family members when there is a family history of mucopolysaccharidosis type IIIB but a disease-causing mutation has not been previously identified.[GHR geneNAGLU]
Blood; CMT2V; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MPS3B; MPS-IIIB; Mut; Mutations; N-acetyl-alpha-glucosaminidase; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UFHSD; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

NAGLU gene full mutation analysis Sequencing Doc (Bld/Tiss)NAGLU gene full mutation analysis in Blood or Tissue by SequencingNAGLU Full Mut Anl Bld/T SeqNAGLU gene full mutation analysisMOLPATHNAGLU gene variant analysis, Blood or tissue specimenFind

Frequently asked questions

Code details

Code94209-4
SystemLOINC
Display nameNAGLU gene full mutation analysis Sequencing Doc (Bld/Tiss)
DescriptionNAGLU gene full mutation analysis
Short nameNAGLU Full Mut Anl Bld/T Seq
ComponentNAGLU gene full mutation analysis
PropertyFind
TimingPt
System (specimen)Bld/Tiss
ScaleDoc
MethodSequencing
ClassMOLPATH
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.68
Last changed2.68

Consumer names

NAGLU gene variant analysis, Blood or tissue specimen

Part names

NAGLU gene full mutation analysisFindPtBld/TissDocSequencingFindingPoint in time (spot)Blood or Tissue

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 94209-4 | HealthAssure